Virtual Diagnostic Market by Application (Ophthalmology, Cardiology, Pulmonology, Gastroenterology, Otolaryngology, Dermatology, Geriatric, Neurology, Orthopedics, Mental Health, Women's Health) by End-User (Physicians/Clinicians (Providers, Hospitals (Urgent and Acute Care Centers, Clinics, Primary Care Centers, Senior Care Facilities, Home–Based care, Others) Payers (Insurance Companies, Others)) Diagnostic Centers, Research Laboratories and Organizations, Others) by Type (Device/Wearable-based and Mobile App-based); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2020 - 2028
Industry Trends
Global virtual diagnostic market is expected to reach US$ 1409.57 million by 2028, growing at a CAGR of 16.71% over the forecast period. Emergency treatment is provided by virtual diagnostics solution providers for patients suffering from chronic illnesses and other high-risk patients who require regular medical consultation exams. Virtual diagnostics helps patients to interact with physicians according to the need of patient. As the next enhancement to the virtual care, healthcare providers see point-of-care testing and remote diagnostic services as primary solutions in order to provide efficient care to the patients. Through this, patients may see a doctor online for a troublesome health condition and have home laboratories and tests, thus, increasing patient interaction and telehealth satisfaction.
The growth of the demand for virtual diagnostics is driven by the rising prevalence of chronic health conditions. Other factors which boost the growth of these solutions are poor health conditions, shortage of doctors and medical personnel in routine diagnosis, these factors are raising the need for virtual diagnosis. Virtual diagnostics are successful in meeting the demand for such diagnostic products. Different factors, including growing understanding of early disease detection and increasing demand for accessible diagnostics are responsible for market development. Progress in technology such as artificial intelligence and machine learning is expected to generate lucrative opportunities in the near future for virtual diagnostic market.
This system, however, is new and includes several challenges which includes low virtual diagnosis accuracy and growing privacy issues, these factors may restrict market development. However, shortage of doctors and medical personnel may alleviate the demand for virtual diagnostic in the years to come. In addition, the rising number of diabetic patients worldwide combined with an increasing preference for self-diagnosis and technological developments in diagnostic technology will fuel the global demand for virtual diagnostics in the coming years. Also, the rise in the geriatric population worldwide and the growth in the prevalence of chronic and infectious diseases worldwide would increase the adoption of virtual diagnostics solutions.
The invention of pathological AI to aid diagnosis would effectively minimise workload of healthcare workers. In addition, increasing adoption of fully automated diagnostic laboratory instruments which are more versatile, high-performance, help minimise hands-on time and eliminate batch testing, would increase the demand for virtual diagnostics in the near future. Also, there is an increase in demand for virtual diagnostics to reduce the false positive detection rate which is expected to accelerate the global market of virtual diagnostics over the forecast period.
The growth in geriatric population globally would fuel the demand for virtual diagnostic over the forecast period. There are 703 million individuals aged 65 or older, according to the United Nations, a figure which is estimated to reach 1.5 billion by 2050. According to the current demographic forecasts and predictions by 2050, 1 in 6 individuals in the world will be over 65 years of age, up from 1 in 11 in 2019. The new estimates also indicate that in the next 30 years, the number of individuals aged 80 or over will triple. This will boost the demand for virtual diagnostic solutions as these solutions helps the patients in eliminating the visits to doctor’s office thus saving time and effort.
Growing adoption of AI in the virtual diagnostic field will fuel the growth of virtual diagnostic industry over the years to come. AI allows predictive diagnosis to be created by algorithms to help doctors choose which patients to prioritise. AI allows doctors to determine which patients to prioritise and assist doctors in the diagnosis of complex or rare diseases. AI diagnostic technology will dramatically reduce the workload of physicians and the processing of image data and the analysis of findings that need to be solved. The use of technology is encouraged by the rise in chronic diseases in rural as well as urban areas and by internet infiltration. In remote areas, the government also supports the launch of such projects and offers financial assistance to families. Smartphones are becoming a norm for the population. Virtual diagnostic solutions enhance clinical results and are time-efficient as well. Virtual diagnostics allows for a higher per-day number of consultations. In response to the growing health epidemic, market leaders are creating customer-centred applications to help users communicate with a professional as per the requirement of patients.
Stakeholders are fighting against time to diagnose a vast number of individuals to curb the spread as the coronavirus pandemic intensifies. The smallest of symptoms trigger a great deal of worry during a pandemic. However, as hospitals and clinics are busy with infected patients, visiting a doctor is not always a viable choice. Virtual diagnostic solutions are experiencing massive demand, especially during the pandemic of COVID-19. The virus has resulted in the deterioration of the healthcare system in different economies. In the current scenario hospitals are filled with infected persons, and rapid adoption of these solutions is being witnessed by the virtual diagnostic industry. Solutions for virtual health risk assessment that enable individuals to get a quick, primary diagnosis of their symptoms alleviate their concern and ease the burden on healthcare systems.
The consumer demand would be fuelled by an increase in public understanding of the benefits of technology, an increase in the need for point-of-care diagnosis and treatment, and the increasing trend of personalised medicine. Rapid technological development provides a lucrative growth of these solutions and also helps to collect an unprecedented volume of data while maintaining safety and security. The market for virtual diagnostics is very broad, with many small and medium-sized manufacturers responsible for a large share of the global market. Throughout the supply chain, the suppliers participating in the industry are desegregated. The main businesses in the sector are well-equipped with large companies and are also active in various research and development activities.
Application Insights
In application the cardiology segment will exhibit significant revenue over the forecast period. One of the leading drivers of the market is the increase in cardiology incidence and the increasing concern for frequent consultations among heart patients. These patients are easily vulnerable to the COVID-19 virus and should have no interaction with patients suffering from the virus in overflowing hospitals. Virtual diagnostic technology thus provides them with a unique way of consulting and preserving their wellbeing with their physicians.
End-User Insights
In end user the physicians/clinicians segment will lead the market over the period. The hospital segment is rapidly introducing technology in remote areas to treat and consult patients. Several hospitals are integrating IoT with their equipment with exhausted personnel, but recent advances are expected to increase funding for the healthcare sector which will in turn boost the demand for the virtual diagnostic industry. The implementation of virtual diagnostics which can recognise the problems of all patients with the aid of AI and machine learning will boom in the clinic section.
Type Insights
In the type segment device/wearable based virtual diagnostic solutions are gaining momentum in the market. The players in the market are providing wearable and devices in order to monitor health and also these devices can provide insights on the patient data in order to make analysis. There is an increase in prevalence of app based virtual diagnostic solution in the market. The adoption of app based solutions in order to provide care has increased globally.
Regional Insights
Over the forecast period, North America region will witness a high growth due to the increased adoption of emerging technology in healthcare systems in the region. Moreover, Asia Pacific region will exhibit a significant CAGR over the forecast period due to the presence of a high geriatric population; the industry is experiencing high demand in this region. In the healthcare sector, the introduction of smart technology would fuel consumer demand. The Chinese government has invested more in the hospital's infrastructure to boost its virtual diagnostic business. Developing countries like Indonesia and Malaysia are providing virtual diagnostics to help low-income individuals gain access to better healthcare.
Virtual Diagnostic Market Revenue & Forecast, (US$ Million), 2020 – 2028
Competitive Landscape
The report provides both, qualitative and quantitative research on virtual diagnostic market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
The major players operating in the market include AliveCor, Inc., CapsoVision, Inc., Digital Diagnostics Inc., dSPACE GmbH, Eyenuk, Inc., hearX IP (Pty) Ltd., Hill-Rom Services, Inc., Infermedica, Medtronic, ResApp Health Limited, Sight Diagnostics Ltd, SkinVision, Teckel Medical and other market participants.
Virtual Diagnostic Market:
- By Application
- Ophthalmology
- Cardiology
- Pulmonology
- Gastroenterology
- Otolaryngology
- Dermatology
- Geriatric
- Neurology
- Orthopedics
- Mental Health
- Women's Health
- By End-User
- Physicians/Clinicians
- Providers
- Hospitals
- Urgent and Acute Care Centers
- Clinics
- Primary Care Centers
- Senior Care Facilities
- Home –Based care
- Others
- Payers
- Insurance Companies
- Others
- Diagnostic Centers
- Research Laboratories and Organizations
- Others
- By Type
- Device/Wearable-based
- Mobile App-based
- By Region:
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market
Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2018
1.2.2. Base
Year: 2019
1.2.3. Forecast
Years: 2020 – 2028
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Virtual Diagnostic Market
6. Market
Synopsis: Virtual Diagnostic Market
7. Virtual
Diagnostic Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Virtual Diagnostic Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Virtual Diagnostic Market
7.6. Porter’s Five Force Analysis
7.7. Impact of
Covid-19 on Virtual Diagnostic Market
8. Global
Virtual Diagnostic Market Analysis and Forecasts, 2020 – 2028
8.1. Overview
8.1.1. Global
Virtual Diagnostic Market Revenue (US$ Mn)
8.2. Global
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
8.2.1. Ophthalmology
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 – 2019
8.2.1.3. Market
Forecast, 2020 – 2028
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 – 2019
8.2.1.5.1.2. Market
Forecast, 2020 – 2028
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 – 2019
8.2.1.5.2.2. Market
Forecast, 2020 – 2028
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 – 2019
8.2.1.5.3.2. Market
Forecast, 2020 – 2028
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 – 2019
8.2.1.5.4.2. Market
Forecast, 2020 – 2028
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 – 2019
8.2.1.5.5.2. Market
Forecast, 2020 – 2028
8.2.2. Cardiology
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 – 2019
8.2.2.3. Market
Forecast, 2020 – 2028
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 – 2019
8.2.2.5.1.2. Market
Forecast, 2020 – 2028
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 – 2019
8.2.2.5.2.2. Market
Forecast, 2020 – 2028
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 – 2019
8.2.2.5.3.2. Market
Forecast, 2020 – 2028
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 – 2019
8.2.2.5.4.2. Market
Forecast, 2020 – 2028
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 – 2019
8.2.2.5.5.2. Market
Forecast, 2020 – 2028
8.2.3. Pulmonology
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 – 2019
8.2.3.3. Market
Forecast, 2020 – 2028
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 – 2019
8.2.3.5.1.2. Market
Forecast, 2020 – 2028
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 – 2019
8.2.3.5.2.2. Market
Forecast, 2020 – 2028
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 – 2019
8.2.3.5.3.2. Market
Forecast, 2020 – 2028
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 – 2019
8.2.3.5.4.2. Market
Forecast, 2020 – 2028
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 – 2019
8.2.3.5.5.2. Market
Forecast, 2020 – 2028
8.2.4. Gastroenterology
8.2.4.1. Definition
8.2.4.2. Market
Estimation and Penetration, 2015 – 2019
8.2.4.3. Market
Forecast, 2020 – 2028
8.2.4.4. Compound
Annual Growth Rate (CAGR)
8.2.4.5. Regional
Bifurcation
8.2.4.5.1. North
America
8.2.4.5.1.1. Market
Estimation, 2015 – 2019
8.2.4.5.1.2. Market
Forecast, 2020 – 2028
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 – 2019
8.2.4.5.2.2. Market
Forecast, 2020 – 2028
8.2.4.5.3. Asia
Pacific
8.2.4.5.3.1. Market
Estimation, 2015 – 2019
8.2.4.5.3.2. Market
Forecast, 2020 – 2028
8.2.4.5.4. Middle
East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 – 2019
8.2.4.5.4.2. Market
Forecast, 2020 – 2028
8.2.4.5.5. Latin
America
8.2.4.5.5.1. Market
Estimation, 2015 – 2019
8.2.4.5.5.2. Market
Forecast, 2020 – 2028
8.2.5. Otolaryngology
8.2.5.1. Definition
8.2.5.2. Market
Estimation and Penetration, 2015 – 2019
8.2.5.3. Market
Forecast, 2020 – 2028
8.2.5.4. Compound
Annual Growth Rate (CAGR)
8.2.5.5. Regional
Bifurcation
8.2.5.5.1. North
America
8.2.5.5.1.1. Market
Estimation, 2015 – 2019
8.2.5.5.1.2. Market
Forecast, 2020 – 2028
8.2.5.5.2. Europe
8.2.5.5.2.1. Market
Estimation, 2015 – 2019
8.2.5.5.2.2. Market
Forecast, 2020 – 2028
8.2.5.5.3. Asia
Pacific
8.2.5.5.3.1. Market
Estimation, 2015 – 2019
8.2.5.5.3.2. Market
Forecast, 2020 – 2028
8.2.5.5.4. Middle
East and Africa
8.2.5.5.4.1. Market
Estimation, 2015 – 2019
8.2.5.5.4.2. Market
Forecast, 2020 – 2028
8.2.5.5.5. Latin
America
8.2.5.5.5.1. Market
Estimation, 2015 – 2019
8.2.5.5.5.2. Market
Forecast, 2020 – 2028
8.2.6. Dermatology
8.2.6.1. Definition
8.2.6.2. Market
Estimation and Penetration, 2015 – 2019
8.2.6.3. Market
Forecast, 2020 – 2028
8.2.6.4. Compound
Annual Growth Rate (CAGR)
8.2.6.5. Regional
Bifurcation
8.2.6.5.1. North
America
8.2.6.5.1.1. Market
Estimation, 2015 – 2019
8.2.6.5.1.2. Market
Forecast, 2020 – 2028
8.2.6.5.2. Europe
8.2.6.5.2.1. Market
Estimation, 2015 – 2019
8.2.6.5.2.2. Market
Forecast, 2020 – 2028
8.2.6.5.3. Asia
Pacific
8.2.6.5.3.1. Market
Estimation, 2015 – 2019
8.2.6.5.3.2. Market
Forecast, 2020 – 2028
8.2.6.5.4. Middle
East and Africa
8.2.6.5.4.1. Market
Estimation, 2015 – 2019
8.2.6.5.4.2. Market
Forecast, 2020 – 2028
8.2.6.5.5. Latin
America
8.2.6.5.5.1. Market
Estimation, 2015 – 2019
8.2.6.5.5.2. Market
Forecast, 2020 – 2028
8.2.7. Geriatric
8.2.7.1. Definition
8.2.7.2. Market
Estimation and Penetration, 2015 – 2019
8.2.7.3. Market
Forecast, 2020 – 2028
8.2.7.4. Compound
Annual Growth Rate (CAGR)
8.2.7.5. Regional
Bifurcation
8.2.7.5.1. North
America
8.2.7.5.1.1. Market
Estimation, 2015 – 2019
8.2.7.5.1.2. Market
Forecast, 2020 – 2028
8.2.7.5.2. Europe
8.2.7.5.2.1. Market
Estimation, 2015 – 2019
8.2.7.5.2.2. Market
Forecast, 2020 – 2028
8.2.7.5.3. Asia
Pacific
8.2.7.5.3.1. Market
Estimation, 2015 – 2019
8.2.7.5.3.2. Market
Forecast, 2020 – 2028
8.2.7.5.4. Middle
East and Africa
8.2.7.5.4.1. Market
Estimation, 2015 – 2019
8.2.7.5.4.2. Market
Forecast, 2020 – 2028
8.2.7.5.5. Latin
America
8.2.7.5.5.1. Market
Estimation, 2015 – 2019
8.2.7.5.5.2. Market
Forecast, 2020 – 2028
8.2.8. Neurology
8.2.8.1. Definition
8.2.8.2. Market
Estimation and Penetration, 2015 – 2019
8.2.8.3. Market
Forecast, 2020 – 2028
8.2.8.4. Compound
Annual Growth Rate (CAGR)
8.2.8.5. Regional
Bifurcation
8.2.8.5.1. North
America
8.2.8.5.1.1. Market
Estimation, 2015 – 2019
8.2.8.5.1.2. Market
Forecast, 2020 – 2028
8.2.8.5.2. Europe
8.2.8.5.2.1. Market
Estimation, 2015 – 2019
8.2.8.5.2.2. Market
Forecast, 2020 – 2028
8.2.8.5.3. Asia
Pacific
8.2.8.5.3.1. Market
Estimation, 2015 – 2019
8.2.8.5.3.2. Market
Forecast, 2020 – 2028
8.2.8.5.4. Middle
East and Africa
8.2.8.5.4.1. Market
Estimation, 2015 – 2019
8.2.8.5.4.2. Market
Forecast, 2020 – 2028
8.2.8.5.5. Latin
America
8.2.8.5.5.1. Market
Estimation, 2015 – 2019
8.2.8.5.5.2. Market
Forecast, 2020 – 2028
8.2.9. Orthopedics
8.2.9.1. Definition
8.2.9.2. Market
Estimation and Penetration, 2015 – 2019
8.2.9.3. Market
Forecast, 2020 – 2028
8.2.9.4. Compound
Annual Growth Rate (CAGR)
8.2.9.5. Regional
Bifurcation
8.2.9.5.1. North
America
8.2.9.5.1.1. Market
Estimation, 2015 – 2019
8.2.9.5.1.2. Market
Forecast, 2020 – 2028
8.2.9.5.2. Europe
8.2.9.5.2.1. Market
Estimation, 2015 – 2019
8.2.9.5.2.2. Market
Forecast, 2020 – 2028
8.2.9.5.3. Asia
Pacific
8.2.9.5.3.1. Market
Estimation, 2015 – 2019
8.2.9.5.3.2. Market
Forecast, 2020 – 2028
8.2.9.5.4. Middle
East and Africa
8.2.9.5.4.1. Market
Estimation, 2015 – 2019
8.2.9.5.4.2. Market
Forecast, 2020 – 2028
8.2.9.5.5. Latin
America
8.2.9.5.5.1. Market
Estimation, 2015 – 2019
8.2.9.5.5.2. Market
Forecast, 2020 – 2028
8.2.10. Mental
Health
8.2.10.1. Definition
8.2.10.2. Market
Estimation and Penetration, 2015 – 2019
8.2.10.3. Market
Forecast, 2020 – 2028
8.2.10.4. Compound
Annual Growth Rate (CAGR)
8.2.10.5. Regional
Bifurcation
8.2.10.5.1. North
America
8.2.10.5.1.1. Market
Estimation, 2015 – 2019
8.2.10.5.1.2. Market
Forecast, 2020 – 2028
8.2.10.5.2. Europe
8.2.10.5.2.1. Market
Estimation, 2015 – 2019
8.2.10.5.2.2. Market
Forecast, 2020 – 2028
8.2.10.5.3. Asia
Pacific
8.2.10.5.3.1. Market
Estimation, 2015 – 2019
8.2.10.5.3.2. Market
Forecast, 2020 – 2028
8.2.10.5.4. Middle
East and Africa
8.2.10.5.4.1. Market
Estimation, 2015 – 2019
8.2.10.5.4.2. Market
Forecast, 2020 – 2028
8.2.10.5.5. Latin
America
8.2.10.5.5.1. Market
Estimation, 2015 – 2019
8.2.10.5.5.2. Market
Forecast, 2020 – 2028
8.2.11. Women's
Health
8.2.11.1. Definition
8.2.11.2. Market
Estimation and Penetration, 2015 – 2019
8.2.11.3. Market
Forecast, 2020 – 2028
8.2.11.4. Compound
Annual Growth Rate (CAGR)
8.2.11.5. Regional
Bifurcation
8.2.11.5.1. North
America
8.2.11.5.1.1. Market
Estimation, 2015 – 2019
8.2.11.5.1.2. Market
Forecast, 2020 – 2028
8.2.11.5.2. Europe
8.2.11.5.2.1. Market
Estimation, 2015 – 2019
8.2.11.5.2.2. Market
Forecast, 2020 – 2028
8.2.11.5.3. Asia
Pacific
8.2.11.5.3.1. Market
Estimation, 2015 – 2019
8.2.11.5.3.2. Market
Forecast, 2020 – 2028
8.2.11.5.4. Middle
East and Africa
8.2.11.5.4.1. Market
Estimation, 2015 – 2019
8.2.11.5.4.2. Market
Forecast, 2020 – 2028
8.2.11.5.5. Latin
America
8.2.11.5.5.1. Market
Estimation, 2015 – 2019
8.2.11.5.5.2. Market
Forecast, 2020 – 2028
8.2.12. Others
8.2.12.1. Definition
8.2.12.2. Market
Estimation and Penetration, 2015 – 2019
8.2.12.3. Market
Forecast, 2020 – 2028
8.2.12.4. Compound
Annual Growth Rate (CAGR)
8.2.12.5. Regional
Bifurcation
8.2.12.5.1. North
America
8.2.12.5.1.1. Market
Estimation, 2015 – 2019
8.2.12.5.1.2. Market
Forecast, 2020 – 2028
8.2.12.5.2. Europe
8.2.12.5.2.1. Market
Estimation, 2015 – 2019
8.2.12.5.2.2. Market
Forecast, 2020 – 2028
8.2.12.5.3. Asia
Pacific
8.2.12.5.3.1. Market
Estimation, 2015 – 2019
8.2.12.5.3.2. Market
Forecast, 2020 – 2028
8.2.12.5.4. Middle
East and Africa
8.2.12.5.4.1. Market
Estimation, 2015 – 2019
8.2.12.5.4.2. Market
Forecast, 2020 – 2028
8.2.12.5.5. Latin
America
8.2.12.5.5.1. Market
Estimation, 2015 – 2019
8.2.12.5.5.2. Market
Forecast, 2020 – 2028
8.3. Key
Segment for Channeling Investments
8.3.1. By
Application
9. Global
Virtual Diagnostic Market Analysis and Forecasts, 2020 – 2028
9.1. Overview
9.2. Global
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
9.2.1. Physicians/Clinicians
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 – 2019
9.2.1.3. Market
Forecast, 2020 – 2028
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 – 2019
9.2.1.5.1.2. Market
Forecast, 2020 – 2028
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2019
9.2.1.5.2.2. Market
Forecast, 2020 – 2028
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2019
9.2.1.5.3.2. Market
Forecast, 2020 – 2028
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2019
9.2.1.5.4.2. Market
Forecast, 2020 – 2028
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 – 2019
9.2.1.5.5.2. Market
Forecast, 2020 – 2028
9.2.2. Providers
(Definition, Market Estimation and Penetration, 2015 – 2019, Market Estimation
(2015 – 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Hospitals, Urgent and Acute Care
Centers, Clinics, Primary Care Centers, Senior Care Facilities, Home –Based
care, Others)
9.2.2.1. Hospitals
9.2.2.2. Urgent
and Acute Care Centers
9.2.2.3. Clinics
9.2.2.4. Primary
Care Centers
9.2.2.5. Senior
Care Facilities
9.2.2.6. Home
–Based care
9.2.2.7. Others
9.2.3. Payers
(Definition, Market Estimation and Penetration, 2015 – 2019, Market Estimation
(2015 – 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Insurance Companies, Others)
9.2.3.1. Insurance
Companies
9.2.3.2. Others
9.2.4. Diagnostic
Centers
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2015 – 2019
9.2.4.3. Market
Forecast, 2020 – 2028
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market
Estimation, 2015 – 2019
9.2.4.5.1.2. Market
Forecast, 2020 – 2028
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 – 2019
9.2.4.5.2.2. Market
Forecast, 2020 – 2028
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market
Estimation, 2015 – 2019
9.2.4.5.3.2. Market
Forecast, 2020 – 2028
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 – 2019
9.2.4.5.4.2. Market
Forecast, 2020 – 2028
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market
Estimation, 2015 – 2019
9.2.4.5.5.2. Market
Forecast, 2020 – 2028
9.2.5. Research
Laboratories and Organizations
9.2.5.1. Definition
9.2.5.2. Market
Estimation and Penetration, 2015 – 2019
9.2.5.3. Market
Forecast, 2020 – 2028
9.2.5.4. Compound
Annual Growth Rate (CAGR)
9.2.5.5. Regional
Bifurcation
9.2.5.5.1. North
America
9.2.5.5.1.1. Market
Estimation, 2015 – 2019
9.2.5.5.1.2. Market
Forecast, 2020 – 2028
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 – 2019
9.2.5.5.2.2. Market
Forecast, 2020 – 2028
9.2.5.5.3. Asia
Pacific
9.2.5.5.3.1. Market
Estimation, 2015 – 2019
9.2.5.5.3.2. Market
Forecast, 2020 – 2028
9.2.5.5.4. Middle
East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 – 2019
9.2.5.5.4.2. Market
Forecast, 2020 – 2028
9.2.5.5.5. Latin
America
9.2.5.5.5.1. Market
Estimation, 2015 – 2019
9.2.5.5.5.2. Market
Forecast, 2020 – 2028
9.2.6. Others
9.2.6.1. Definition
9.2.6.2. Market
Estimation and Penetration, 2015 – 2019
9.2.6.3. Market
Forecast, 2020 – 2028
9.2.6.4. Compound
Annual Growth Rate (CAGR)
9.2.6.5. Regional
Bifurcation
9.2.6.5.1. North
America
9.2.6.5.1.1. Market
Estimation, 2015 – 2019
9.2.6.5.1.2. Market
Forecast, 2020 – 2028
9.2.6.5.2. Europe
9.2.6.5.2.1. Market
Estimation, 2015 – 2019
9.2.6.5.2.2. Market
Forecast, 2020 – 2028
9.2.6.5.3. Asia
Pacific
9.2.6.5.3.1. Market
Estimation, 2015 – 2019
9.2.6.5.3.2. Market
Forecast, 2020 – 2028
9.2.6.5.4. Middle
East and Africa
9.2.6.5.4.1. Market
Estimation, 2015 – 2019
9.2.6.5.4.2. Market
Forecast, 2020 – 2028
9.2.6.5.5. Latin
America
9.2.6.5.5.1. Market
Estimation, 2015 – 2019
9.2.6.5.5.2. Market
Forecast, 2020 – 2028
9.3. Key
Segment for Channeling Investments
9.3.1. By
End-User
10. Global
Virtual Diagnostic Market Analysis and Forecasts, 2020 – 2028
10.1. Overview
10.2. Global
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
10.2.1. Device/Wearable-based
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 – 2019
10.2.1.3. Market
Forecast, 2020 – 2028
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 – 2019
10.2.1.5.1.2. Market
Forecast, 2020 – 2028
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 – 2019
10.2.1.5.2.2. Market
Forecast, 2020 – 2028
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 – 2019
10.2.1.5.3.2. Market
Forecast, 2020 – 2028
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 – 2019
10.2.1.5.4.2. Market
Forecast, 2020 – 2028
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 – 2019
10.2.1.5.5.2. Market
Forecast, 2020 – 2028
10.2.2. Mobile
App-based
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 – 2019
10.2.2.3. Market
Forecast, 2020 – 2028
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 – 2019
10.2.2.5.1.2. Market
Forecast, 2020 – 2028
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 – 2019
10.2.2.5.2.2. Market
Forecast, 2020 – 2028
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 – 2019
10.2.2.5.3.2. Market
Forecast, 2020 – 2028
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 – 2019
10.2.2.5.4.2. Market
Forecast, 2020 – 2028
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 – 2019
10.2.2.5.5.2. Market
Forecast, 2020 – 2028
10.3. Key
Segment for Channeling Investments
10.3.1. By Type
11. North
America Virtual Diagnostic Market Analysis and Forecasts, 2020 - 2028
11.1. Overview
11.1.1. North
America Virtual Diagnostic Market Revenue (US$ Mn)
11.2. North
America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
Application
11.2.1. Ophthalmology
11.2.2. Cardiology
11.2.3. Pulmonology
11.2.4. Gastroenterology
11.2.5. Otolaryngology
11.2.6. Dermatology
11.2.7. Geriatric
11.2.8. Neurology
11.2.9. Orthopedics
11.2.10. Mental
Health
11.2.11. Women's
Health
11.2.12. Others
11.3. North
America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
11.3.1. Physicians/Clinicians
11.3.2. Providers
11.3.2.1. Hospitals
11.3.2.2. Urgent
and Acute Care Centers
11.3.2.3. Clinics
11.3.2.4. Primary
Care Centers
11.3.2.5. Senior
Care Facilities
11.3.2.6. Home
–Based care
11.3.2.7. Others
11.3.3. Payers
11.3.3.1. Insurance
Companies
11.3.3.2. Others
11.3.4. Diagnostic
Centers
11.3.5. Research
Laboratories and Organizations
11.3.6. Others
11.4. North
America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
11.4.1. Device/Wearable-based
11.4.2. Mobile
App-based
11.5. North
America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
11.5.1.1.1. Ophthalmology
11.5.1.1.2. Cardiology
11.5.1.1.3. Pulmonology
11.5.1.1.4. Gastroenterology
11.5.1.1.5. Otolaryngology
11.5.1.1.6. Dermatology
11.5.1.1.7. Geriatric
11.5.1.1.8. Neurology
11.5.1.1.9. Orthopedics
11.5.1.1.10. Mental
Health
11.5.1.1.11. Women's
Health
11.5.1.1.12. Others
11.5.1.2. U.S
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
11.5.1.2.1. Physicians/Clinicians
11.5.1.2.2. Providers
11.5.1.2.2.1. Hospitals
11.5.1.2.2.2. Urgent
and Acute Care Centers
11.5.1.2.2.3. Clinics
11.5.1.2.2.4. Primary
Care Centers
11.5.1.2.2.5. Senior
Care Facilities
11.5.1.2.2.6. Home
–Based care
11.5.1.2.2.7. Others
11.5.1.2.3. Payers
11.5.1.2.3.1. Insurance
Companies
11.5.1.2.3.2. Others
11.5.1.2.4. Diagnostic
Centers
11.5.1.2.5. Research
Laboratories and Organizations
11.5.1.2.6. Others
11.5.1.3. U.S
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
11.5.1.3.1. Device/Wearable-based
11.5.1.3.2. Mobile
App-based
11.5.2. Canada
11.5.2.1. Canada
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
11.5.2.1.1. Ophthalmology
11.5.2.1.2. Cardiology
11.5.2.1.3. Pulmonology
11.5.2.1.4. Gastroenterology
11.5.2.1.5. Otolaryngology
11.5.2.1.6. Dermatology
11.5.2.1.7. Geriatric
11.5.2.1.8. Neurology
11.5.2.1.9. Orthopedics
11.5.2.1.10. Mental
Health
11.5.2.1.11. Women's
Health
11.5.2.1.12. Others
11.5.2.2. Canada
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
11.5.2.2.1. Physicians/Clinicians
11.5.2.2.2. Providers
11.5.2.2.2.1. Hospitals
11.5.2.2.2.2. Urgent
and Acute Care Centers
11.5.2.2.2.3. Clinics
11.5.2.2.2.4. Primary
Care Centers
11.5.2.2.2.5. Senior
Care Facilities
11.5.2.2.2.6. Home
–Based care
11.5.2.2.2.7. Others
11.5.2.2.3. Payers
11.5.2.2.3.1. Insurance
Companies
11.5.2.2.3.2. Others
11.5.2.2.4. Diagnostic
Centers
11.5.2.2.5. Research
Laboratories and Organizations
11.5.2.2.6. Others
11.5.2.3. Canada
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
11.5.2.3.1. Device/Wearable-based
11.5.2.3.2. Mobile
App-based
11.5.3. Mexico
11.5.3.1. Mexico
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
11.5.3.1.1. Ophthalmology
11.5.3.1.2. Cardiology
11.5.3.1.3. Pulmonology
11.5.3.1.4. Gastroenterology
11.5.3.1.5. Otolaryngology
11.5.3.1.6. Dermatology
11.5.3.1.7. Geriatric
11.5.3.1.8. Neurology
11.5.3.1.9. Orthopedics
11.5.3.1.10. Mental
Health
11.5.3.1.11. Women's
Health
11.5.3.1.12. Others
11.5.3.2. Mexico
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
11.5.3.2.1. Physicians/Clinicians
11.5.3.2.2. Providers
11.5.3.2.2.1. Hospitals
11.5.3.2.2.2. Urgent
and Acute Care Centers
11.5.3.2.2.3. Clinics
11.5.3.2.2.4. Primary
Care Centers
11.5.3.2.2.5. Senior
Care Facilities
11.5.3.2.2.6. Home
–Based care
11.5.3.2.2.7. Others
11.5.3.2.3. Payers
11.5.3.2.3.1. Insurance
Companies
11.5.3.2.3.2. Others
11.5.3.2.4. Diagnostic
Centers
11.5.3.2.5. Research
Laboratories and Organizations
11.5.3.2.6. Others
11.5.3.3. Mexico
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
11.5.3.3.1. Device/Wearable-based
11.5.3.3.2. Mobile
App-based
11.5.4. Rest of
North America
11.5.4.1. Rest
of North America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
Application
11.5.4.1.1. Ophthalmology
11.5.4.1.2. Cardiology
11.5.4.1.3. Pulmonology
11.5.4.1.4. Gastroenterology
11.5.4.1.5. Otolaryngology
11.5.4.1.6. Dermatology
11.5.4.1.7. Geriatric
11.5.4.1.8. Neurology
11.5.4.1.9. Orthopedics
11.5.4.1.10. Mental
Health
11.5.4.1.11. Women's
Health
11.5.4.1.12. Others
11.5.4.2. Rest
of North America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
End-User
11.5.4.2.1. Physicians/Clinicians
11.5.4.2.2. Providers
11.5.4.2.2.1. Hospitals
11.5.4.2.2.2. Urgent
and Acute Care Centers
11.5.4.2.2.3. Clinics
11.5.4.2.2.4. Primary
Care Centers
11.5.4.2.2.5. Senior
Care Facilities
11.5.4.2.2.6. Home
–Based care
11.5.4.2.2.7. Others
11.5.4.2.3. Payers
11.5.4.2.3.1. Insurance
Companies
11.5.4.2.3.2. Others
11.5.4.2.4. Diagnostic
Centers
11.5.4.2.5. Research
Laboratories and Organizations
11.5.4.2.6. Others
11.5.4.3. Rest
of North America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
Type
11.5.4.3.1. Device/Wearable-based
11.5.4.3.2. Mobile
App-based
11.6. Key
Segment for Channeling Investments
11.6.1. By
Country
11.6.2. By
Application
11.6.3. By
End-User
11.6.4. By Type
12. Europe
Virtual Diagnostic Market Analysis and Forecasts, 2020 - 2028
12.1. Overview
12.1.1. Europe
Virtual Diagnostic Market Revenue (US$ Mn)
12.2. Europe
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
12.2.1. Ophthalmology
12.2.2. Cardiology
12.2.3. Pulmonology
12.2.4. Gastroenterology
12.2.5. Otolaryngology
12.2.6. Dermatology
12.2.7. Geriatric
12.2.8. Neurology
12.2.9. Orthopedics
12.2.10. Mental
Health
12.2.11. Women's
Health
12.2.12. Others
12.3. Europe
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
12.3.1. Physicians/Clinicians
12.3.2. Providers
12.3.2.1. Hospitals
12.3.2.2. Urgent
and Acute Care Centers
12.3.2.3. Clinics
12.3.2.4. Primary
Care Centers
12.3.2.5. Senior
Care Facilities
12.3.2.6. Home
–Based care
12.3.2.7. Others
12.3.3. Payers
12.3.3.1. Insurance
Companies
12.3.3.2. Others
12.3.4. Diagnostic
Centers
12.3.5. Research
Laboratories and Organizations
12.3.6. Others
12.4. Europe
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
12.4.1. Device/Wearable-based
12.4.2. Mobile
App-based
12.5. Europe
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1. France
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
12.5.1.1.1. Ophthalmology
12.5.1.1.2. Cardiology
12.5.1.1.3. Pulmonology
12.5.1.1.4. Gastroenterology
12.5.1.1.5. Otolaryngology
12.5.1.1.6. Dermatology
12.5.1.1.7. Geriatric
12.5.1.1.8. Neurology
12.5.1.1.9. Orthopedics
12.5.1.1.10. Mental
Health
12.5.1.1.11. Women's
Health
12.5.1.1.12. Others
12.5.1.2. France
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
12.5.1.2.1. Physicians/Clinicians
12.5.1.2.2. Providers
12.5.1.2.2.1. Hospitals
12.5.1.2.2.2. Urgent
and Acute Care Centers
12.5.1.2.2.3. Clinics
12.5.1.2.2.4. Primary
Care Centers
12.5.1.2.2.5. Senior
Care Facilities
12.5.1.2.2.6. Home
–Based care
12.5.1.2.2.7. Others
12.5.1.2.3. Payers
12.5.1.2.3.1. Insurance
Companies
12.5.1.2.3.2. Others
12.5.1.2.4. Diagnostic
Centers
12.5.1.2.5. Research
Laboratories and Organizations
12.5.1.2.6. Others
12.5.1.3. France
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
12.5.1.3.1. Device/Wearable-based
12.5.1.3.2. Mobile
App-based
12.5.2. The UK
12.5.2.1. The
UK Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
12.5.2.1.1. Ophthalmology
12.5.2.1.2. Cardiology
12.5.2.1.3. Pulmonology
12.5.2.1.4. Gastroenterology
12.5.2.1.5. Otolaryngology
12.5.2.1.6. Dermatology
12.5.2.1.7. Geriatric
12.5.2.1.8. Neurology
12.5.2.1.9. Orthopedics
12.5.2.1.10. Mental
Health
12.5.2.1.11. Women's
Health
12.5.2.1.12. Others
12.5.2.2. The
UK Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
12.5.2.2.1. Physicians/Clinicians
12.5.2.2.2. Providers
12.5.2.2.2.1. Hospitals
12.5.2.2.2.2. Urgent
and Acute Care Centers
12.5.2.2.2.3. Clinics
12.5.2.2.2.4. Primary
Care Centers
12.5.2.2.2.5. Senior
Care Facilities
12.5.2.2.2.6. Home
–Based care
12.5.2.2.2.7. Others
12.5.2.2.3. Payers
12.5.2.2.3.1. Insurance
Companies
12.5.2.2.3.2. Others
12.5.2.2.4. Diagnostic
Centers
12.5.2.2.5. Research
Laboratories and Organizations
12.5.2.2.6. Others
12.5.2.3. The
UK Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
12.5.2.3.1. Device/Wearable-based
12.5.2.3.2. Mobile
App-based
12.5.3. Spain
12.5.3.1. Spain
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
12.5.3.1.1. Ophthalmology
12.5.3.1.2. Cardiology
12.5.3.1.3. Pulmonology
12.5.3.1.4. Gastroenterology
12.5.3.1.5. Otolaryngology
12.5.3.1.6. Dermatology
12.5.3.1.7. Geriatric
12.5.3.1.8. Neurology
12.5.3.1.9. Orthopedics
12.5.3.1.10. Mental
Health
12.5.3.1.11. Women's
Health
12.5.3.1.12. Others
12.5.3.2. Spain
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
12.5.3.2.1. Physicians/Clinicians
12.5.3.2.2. Providers
12.5.3.2.2.1. Hospitals
12.5.3.2.2.2. Urgent
and Acute Care Centers
12.5.3.2.2.3. Clinics
12.5.3.2.2.4. Primary
Care Centers
12.5.3.2.2.5. Senior
Care Facilities
12.5.3.2.2.6. Home
–Based care
12.5.3.2.2.7. Others
12.5.3.2.3. Payers
12.5.3.2.3.1. Insurance
Companies
12.5.3.2.3.2. Others
12.5.3.2.4. Diagnostic
Centers
12.5.3.2.5. Research
Laboratories and Organizations
12.5.3.2.6. Others
12.5.3.3. Spain
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
12.5.3.3.1. Device/Wearable-based
12.5.3.3.2. Mobile
App-based
12.5.4. Germany
12.5.4.1. Germany
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
12.5.4.1.1. Ophthalmology
12.5.4.1.2. Cardiology
12.5.4.1.3. Pulmonology
12.5.4.1.4. Gastroenterology
12.5.4.1.5. Otolaryngology
12.5.4.1.6. Dermatology
12.5.4.1.7. Geriatric
12.5.4.1.8. Neurology
12.5.4.1.9. Orthopedics
12.5.4.1.10. Mental
Health
12.5.4.1.11. Women's
Health
12.5.4.1.12. Others
12.5.4.2. Germany
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
12.5.4.2.1. Physicians/Clinicians
12.5.4.2.2. Providers
12.5.4.2.2.1. Hospitals
12.5.4.2.2.2. Urgent
and Acute Care Centers
12.5.4.2.2.3. Clinics
12.5.4.2.2.4. Primary
Care Centers
12.5.4.2.2.5. Senior
Care Facilities
12.5.4.2.2.6. Home
–Based care
12.5.4.2.2.7. Others
12.5.4.2.3. Payers
12.5.4.2.3.1. Insurance
Companies
12.5.4.2.3.2. Others
12.5.4.2.4. Diagnostic
Centers
12.5.4.2.5. Research
Laboratories and Organizations
12.5.4.2.6. Others
12.5.4.3. Germany
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
12.5.4.3.1. Device/Wearable-based
12.5.4.3.2. Mobile
App-based
12.5.5. Italy
12.5.5.1. Italy
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
12.5.5.1.1. Ophthalmology
12.5.5.1.2. Cardiology
12.5.5.1.3. Pulmonology
12.5.5.1.4. Gastroenterology
12.5.5.1.5. Otolaryngology
12.5.5.1.6. Dermatology
12.5.5.1.7. Geriatric
12.5.5.1.8. Neurology
12.5.5.1.9. Orthopedics
12.5.5.1.10. Mental
Health
12.5.5.1.11. Women's
Health
12.5.5.1.12. Others
12.5.5.2. Italy
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
12.5.5.2.1. Physicians/Clinicians
12.5.5.2.2. Providers
12.5.5.2.2.1. Hospitals
12.5.5.2.2.2. Urgent
and Acute Care Centers
12.5.5.2.2.3. Clinics
12.5.5.2.2.4. Primary
Care Centers
12.5.5.2.2.5. Senior
Care Facilities
12.5.5.2.2.6. Home
–Based care
12.5.5.2.2.7. Others
12.5.5.2.3. Payers
12.5.5.2.3.1. Insurance
Companies
12.5.5.2.3.2. Others
12.5.5.2.4. Diagnostic
Centers
12.5.5.2.5. Research
Laboratories and Organizations
12.5.5.2.6. Others
12.5.5.3. Italy
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
12.5.5.3.1. Device/Wearable-based
12.5.5.3.2. Mobile
App-based
12.5.6. Nordic
Countries
12.5.6.1. Nordic
Countries Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
Application
12.5.6.1.1. Ophthalmology
12.5.6.1.2. Cardiology
12.5.6.1.3. Pulmonology
12.5.6.1.4. Gastroenterology
12.5.6.1.5. Otolaryngology
12.5.6.1.6. Dermatology
12.5.6.1.7. Geriatric
12.5.6.1.8. Neurology
12.5.6.1.9. Orthopedics
12.5.6.1.10. Mental
Health
12.5.6.1.11. Women's
Health
12.5.6.1.12. Others
12.5.6.2. Nordic
Countries Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
12.5.6.2.1. Physicians/Clinicians
12.5.6.2.2. Providers
12.5.6.2.2.1. Hospitals
12.5.6.2.2.2. Urgent
and Acute Care Centers
12.5.6.2.2.3. Clinics
12.5.6.2.2.4. Primary
Care Centers
12.5.6.2.2.5. Senior
Care Facilities
12.5.6.2.2.6. Home
–Based care
12.5.6.2.2.7. Others
12.5.6.2.3. Payers
12.5.6.2.3.1. Insurance
Companies
12.5.6.2.3.2. Others
12.5.6.2.4. Diagnostic
Centers
12.5.6.2.5. Research
Laboratories and Organizations
12.5.6.2.6. Others
12.5.6.3. Nordic
Countries Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
12.5.6.3.1. Device/Wearable-based
12.5.6.3.2. Mobile
App-based
12.5.6.4. Nordic
Countries Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux
Union
12.5.7.1. Benelux
Union Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
12.5.7.1.1. Ophthalmology
12.5.7.1.2. Cardiology
12.5.7.1.3. Pulmonology
12.5.7.1.4. Gastroenterology
12.5.7.1.5. Otolaryngology
12.5.7.1.6. Dermatology
12.5.7.1.7. Geriatric
12.5.7.1.8. Neurology
12.5.7.1.9. Orthopedics
12.5.7.1.10. Mental
Health
12.5.7.1.11. Women's
Health
12.5.7.1.12. Others
12.5.7.2. Benelux
Union Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
12.5.7.2.1. Physicians/Clinicians
12.5.7.2.2. Providers
12.5.7.2.2.1. Hospitals
12.5.7.2.2.2. Urgent
and Acute Care Centers
12.5.7.2.2.3. Clinics
12.5.7.2.2.4. Primary
Care Centers
12.5.7.2.2.5. Senior
Care Facilities
12.5.7.2.2.6. Home
–Based care
12.5.7.2.2.7. Others
12.5.7.2.3. Payers
12.5.7.2.3.1. Insurance
Companies
12.5.7.2.3.2. Others
12.5.7.2.4. Diagnostic
Centers
12.5.7.2.5. Research
Laboratories and Organizations
12.5.7.2.6. Others
12.5.7.3. Benelux
Union Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
12.5.7.3.1. Device/Wearable-based
12.5.7.3.2. Mobile
App-based
12.5.7.4. Benelux
Union Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The
Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of
Europe
12.5.8.1. Rest
of Europe Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
Application
12.5.8.1.1. Ophthalmology
12.5.8.1.2. Cardiology
12.5.8.1.3. Pulmonology
12.5.8.1.4. Gastroenterology
12.5.8.1.5. Otolaryngology
12.5.8.1.6. Dermatology
12.5.8.1.7. Geriatric
12.5.8.1.8. Neurology
12.5.8.1.9. Orthopedics
12.5.8.1.10. Mental
Health
12.5.8.1.11. Women's
Health
12.5.8.1.12. Others
12.5.8.2. Rest
of Europe Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
12.5.8.2.1. Physicians/Clinicians
12.5.8.2.2. Providers
12.5.8.2.2.1. Hospitals
12.5.8.2.2.2. Urgent
and Acute Care Centers
12.5.8.2.2.3. Clinics
12.5.8.2.2.4. Primary
Care Centers
12.5.8.2.2.5. Senior
Care Facilities
12.5.8.2.2.6. Home
–Based care
12.5.8.2.2.7. Others
12.5.8.2.3. Payers
12.5.8.2.3.1. Insurance
Companies
12.5.8.2.3.2. Others
12.5.8.2.4. Diagnostic
Centers
12.5.8.2.5. Research
Laboratories and Organizations
12.5.8.2.6. Others
12.5.8.3. Rest
of Europe Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
12.5.8.3.1. Device/Wearable-based
12.5.8.3.2. Mobile
App-based
12.6. Key
Segment for Channeling Investments
12.6.1. By
Country
12.6.2. By
Application
12.6.3. By
End-User
12.6.4. By Type
13. Asia
Pacific Virtual Diagnostic Market Analysis and Forecasts, 2020 - 2028
13.1. Overview
13.1.1. Asia Pacific
Virtual Diagnostic Market Revenue (US$ Mn)
13.2. Asia
Pacific Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
Application
13.2.1. Ophthalmology
13.2.2. Cardiology
13.2.3. Pulmonology
13.2.4. Gastroenterology
13.2.5. Otolaryngology
13.2.6. Dermatology
13.2.7. Geriatric
13.2.8. Neurology
13.2.9. Orthopedics
13.2.10. Mental
Health
13.2.11. Women's
Health
13.2.12. Others
13.3. Asia
Pacific Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
13.3.1. Physicians/Clinicians
13.3.2. Providers
13.3.2.1. Hospitals
13.3.2.2. Urgent
and Acute Care Centers
13.3.2.3. Clinics
13.3.2.4. Primary
Care Centers
13.3.2.5. Senior
Care Facilities
13.3.2.6. Home
–Based care
13.3.2.7. Others
13.3.3. Payers
13.3.3.1. Insurance
Companies
13.3.3.2. Others
13.3.4. Diagnostic
Centers
13.3.5. Research
Laboratories and Organizations
13.3.6. Others
13.4. Asia
Pacific Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
13.4.1. Device/Wearable-based
13.4.2. Mobile
App-based
13.5. Asia
Pacific Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1. China
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
13.5.1.1.1. Ophthalmology
13.5.1.1.2. Cardiology
13.5.1.1.3. Pulmonology
13.5.1.1.4. Gastroenterology
13.5.1.1.5. Otolaryngology
13.5.1.1.6. Dermatology
13.5.1.1.7. Geriatric
13.5.1.1.8. Neurology
13.5.1.1.9. Orthopedics
13.5.1.1.10. Mental
Health
13.5.1.1.11. Women's
Health
13.5.1.1.12. Others
13.5.1.2. China
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
13.5.1.2.1. Physicians/Clinicians
13.5.1.2.2. Providers
13.5.1.2.2.1. Hospitals
13.5.1.2.2.2. Urgent
and Acute Care Centers
13.5.1.2.2.3. Clinics
13.5.1.2.2.4. Primary
Care Centers
13.5.1.2.2.5. Senior
Care Facilities
13.5.1.2.2.6. Home
–Based care
13.5.1.2.2.7. Others
13.5.1.2.3. Payers
13.5.1.2.3.1. Insurance
Companies
13.5.1.2.3.2. Others
13.5.1.2.4. Diagnostic
Centers
13.5.1.2.5. Research
Laboratories and Organizations
13.5.1.2.6. Others
13.5.1.3. China
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
13.5.1.3.1. Device/Wearable-based
13.5.1.3.2. Mobile
App-based
13.5.2. Japan
13.5.2.1. Japan
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
13.5.2.1.1. Ophthalmology
13.5.2.1.2. Cardiology
13.5.2.1.3. Pulmonology
13.5.2.1.4. Gastroenterology
13.5.2.1.5. Otolaryngology
13.5.2.1.6. Dermatology
13.5.2.1.7. Geriatric
13.5.2.1.8. Neurology
13.5.2.1.9. Orthopedics
13.5.2.1.10. Mental
Health
13.5.2.1.11. Women's
Health
13.5.2.1.12. Others
13.5.2.2. Japan
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
13.5.2.2.1. Physicians/Clinicians
13.5.2.2.2. Providers
13.5.2.2.2.1. Hospitals
13.5.2.2.2.2. Urgent
and Acute Care Centers
13.5.2.2.2.3. Clinics
13.5.2.2.2.4. Primary
Care Centers
13.5.2.2.2.5. Senior
Care Facilities
13.5.2.2.2.6. Home
–Based care
13.5.2.2.2.7. Others
13.5.2.2.3. Payers
13.5.2.2.3.1. Insurance
Companies
13.5.2.2.3.2. Others
13.5.2.2.4. Diagnostic
Centers
13.5.2.2.5. Research
Laboratories and Organizations
13.5.2.2.6. Others
13.5.2.3. Japan
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
13.5.2.3.1. Device/Wearable-based
13.5.2.3.2. Mobile
App-based
13.5.3. India
13.5.3.1. India
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
13.5.3.1.1. Ophthalmology
13.5.3.1.2. Cardiology
13.5.3.1.3. Pulmonology
13.5.3.1.4. Gastroenterology
13.5.3.1.5. Otolaryngology
13.5.3.1.6. Dermatology
13.5.3.1.7. Geriatric
13.5.3.1.8. Neurology
13.5.3.1.9. Orthopedics
13.5.3.1.10. Mental
Health
13.5.3.1.11. Women's
Health
13.5.3.1.12. Others
13.5.3.2. India
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
13.5.3.2.1. Physicians/Clinicians
13.5.3.2.2. Providers
13.5.3.2.2.1. Hospitals
13.5.3.2.2.2. Urgent
and Acute Care Centers
13.5.3.2.2.3. Clinics
13.5.3.2.2.4. Primary
Care Centers
13.5.3.2.2.5. Senior
Care Facilities
13.5.3.2.2.6. Home
–Based care
13.5.3.2.2.7. Others
13.5.3.2.3. Payers
13.5.3.2.3.1. Insurance
Companies
13.5.3.2.3.2. Others
13.5.3.2.4. Diagnostic
Centers
13.5.3.2.5. Research
Laboratories and Organizations
13.5.3.2.6. Others
13.5.3.3. India
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
13.5.3.3.1. Device/Wearable-based
13.5.3.3.2. Mobile
App-based
13.5.4. New
Zealand
13.5.4.1. New
Zealand Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
Application
13.5.4.1.1. Ophthalmology
13.5.4.1.2. Cardiology
13.5.4.1.3. Pulmonology
13.5.4.1.4. Gastroenterology
13.5.4.1.5. Otolaryngology
13.5.4.1.6. Dermatology
13.5.4.1.7. Geriatric
13.5.4.1.8. Neurology
13.5.4.1.9. Orthopedics
13.5.4.1.10. Mental
Health
13.5.4.1.11. Women's
Health
13.5.4.1.12. Others
13.5.4.2. New
Zealand Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
13.5.4.2.1. Physicians/Clinicians
13.5.4.2.2. Providers
13.5.4.2.2.1. Hospitals
13.5.4.2.2.2. Urgent
and Acute Care Centers
13.5.4.2.2.3. Clinics
13.5.4.2.2.4. Primary
Care Centers
13.5.4.2.2.5. Senior
Care Facilities
13.5.4.2.2.6. Home
–Based care
13.5.4.2.2.7. Others
13.5.4.2.3. Payers
13.5.4.2.3.1. Insurance
Companies
13.5.4.2.3.2. Others
13.5.4.2.4. Diagnostic
Centers
13.5.4.2.5. Research
Laboratories and Organizations
13.5.4.2.6. Others
13.5.4.3. New
Zealand Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
13.5.4.3.1. Device/Wearable-based
13.5.4.3.2. Mobile
App-based
13.5.5. Australia
13.5.5.1. Australia
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
13.5.5.1.1. Ophthalmology
13.5.5.1.2. Cardiology
13.5.5.1.3. Pulmonology
13.5.5.1.4. Gastroenterology
13.5.5.1.5. Otolaryngology
13.5.5.1.6. Dermatology
13.5.5.1.7. Geriatric
13.5.5.1.8. Neurology
13.5.5.1.9. Orthopedics
13.5.5.1.10. Mental
Health
13.5.5.1.11. Women's
Health
13.5.5.1.12. Others
13.5.5.2. Australia
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
13.5.5.2.1. Physicians/Clinicians
13.5.5.2.2. Providers
13.5.5.2.2.1. Hospitals
13.5.5.2.2.2. Urgent
and Acute Care Centers
13.5.5.2.2.3. Clinics
13.5.5.2.2.4. Primary
Care Centers
13.5.5.2.2.5. Senior
Care Facilities
13.5.5.2.2.6. Home
–Based care
13.5.5.2.2.7. Others
13.5.5.2.3. Payers
13.5.5.2.3.1. Insurance
Companies
13.5.5.2.3.2. Others
13.5.5.2.4. Diagnostic
Centers
13.5.5.2.5. Research
Laboratories and Organizations
13.5.5.2.6. Others
13.5.5.3. Australia
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
13.5.5.3.1. Device/Wearable-based
13.5.5.3.2. Mobile
App-based
13.5.6. South
Korea
13.5.6.1. South
Korea Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
13.5.6.1.1. Ophthalmology
13.5.6.1.2. Cardiology
13.5.6.1.3. Pulmonology
13.5.6.1.4. Gastroenterology
13.5.6.1.5. Otolaryngology
13.5.6.1.6. Dermatology
13.5.6.1.7. Geriatric
13.5.6.1.8. Neurology
13.5.6.1.9. Orthopedics
13.5.6.1.10. Mental
Health
13.5.6.1.11. Women's
Health
13.5.6.1.12. Others
13.5.6.2. South
Korea Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
13.5.6.2.1. Physicians/Clinicians
13.5.6.2.2. Providers
13.5.6.2.2.1. Hospitals
13.5.6.2.2.2. Urgent
and Acute Care Centers
13.5.6.2.2.3. Clinics
13.5.6.2.2.4. Primary
Care Centers
13.5.6.2.2.5. Senior
Care Facilities
13.5.6.2.2.6. Home
–Based care
13.5.6.2.2.7. Others
13.5.6.2.3. Payers
13.5.6.2.3.1. Insurance
Companies
13.5.6.2.3.2. Others
13.5.6.2.4. Diagnostic
Centers
13.5.6.2.5. Research
Laboratories and Organizations
13.5.6.2.6. Others
13.5.6.3. South
Korea Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
13.5.6.3.1. Device/Wearable-based
13.5.6.3.2. Mobile
App-based
13.5.7. Southeast
Asia
13.5.7.1. Southeast
Asia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
13.5.7.1.1. Ophthalmology
13.5.7.1.2. Cardiology
13.5.7.1.3. Pulmonology
13.5.7.1.4. Gastroenterology
13.5.7.1.5. Otolaryngology
13.5.7.1.6. Dermatology
13.5.7.1.7. Geriatric
13.5.7.1.8. Neurology
13.5.7.1.9. Orthopedics
13.5.7.1.10. Mental
Health
13.5.7.1.11. Women's
Health
13.5.7.1.12. Others
13.5.7.2. Southeast
Asia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
13.5.7.2.1. Physicians/Clinicians
13.5.7.2.2. Providers
13.5.7.2.2.1. Hospitals
13.5.7.2.2.2. Urgent
and Acute Care Centers
13.5.7.2.2.3. Clinics
13.5.7.2.2.4. Primary
Care Centers
13.5.7.2.2.5. Senior
Care Facilities
13.5.7.2.2.6. Home
–Based care
13.5.7.2.2.7. Others
13.5.7.2.3. Payers
13.5.7.2.3.1. Insurance
Companies
13.5.7.2.3.2. Others
13.5.7.2.4. Diagnostic
Centers
13.5.7.2.5. Research
Laboratories and Organizations
13.5.7.2.6. Others
13.5.7.3. Southeast
Asia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
13.5.7.3.1. Device/Wearable-based
13.5.7.3.2. Mobile
App-based
13.5.7.4. Southeast
Asia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest
of Southeast Asia
13.5.8. Rest of
Asia Pacific
13.5.8.1. Rest
of Asia Pacific Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
Application
13.5.8.1.1. Ophthalmology
13.5.8.1.2. Cardiology
13.5.8.1.3. Pulmonology
13.5.8.1.4. Gastroenterology
13.5.8.1.5. Otolaryngology
13.5.8.1.6. Dermatology
13.5.8.1.7. Geriatric
13.5.8.1.8. Neurology
13.5.8.1.9. Orthopedics
13.5.8.1.10. Mental
Health
13.5.8.1.11. Women's
Health
13.5.8.1.12. Others
13.5.8.2. Rest
of Asia Pacific Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
End-User
13.5.8.2.1. Physicians/Clinicians
13.5.8.2.2. Providers
13.5.8.2.2.1. Hospitals
13.5.8.2.2.2. Urgent
and Acute Care Centers
13.5.8.2.2.3. Clinics
13.5.8.2.2.4. Primary
Care Centers
13.5.8.2.2.5. Senior
Care Facilities
13.5.8.2.2.6. Home
–Based care
13.5.8.2.2.7. Others
13.5.8.2.3. Payers
13.5.8.2.3.1. Insurance
Companies
13.5.8.2.3.2. Others
13.5.8.2.4. Diagnostic
Centers
13.5.8.2.5. Research
Laboratories and Organizations
13.5.8.2.6. Others
13.5.8.3. Rest
of Asia Pacific Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
Type
13.5.8.3.1. Device/Wearable-based
13.5.8.3.2. Mobile
App-based
13.6. Key
Segment for Channeling Investments
13.6.1. By
Country
13.6.2. By
Application
13.6.3. By
End-User
13.6.4. By Type
14. Middle
East and Africa Virtual Diagnostic Market Analysis and Forecasts, 2020 - 2028
14.1. Overview
14.1.1. Middle
East and Africa Virtual Diagnostic Market Revenue (US$ Mn)
14.2. Middle
East and Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
Application
14.2.1. Ophthalmology
14.2.2. Cardiology
14.2.3. Pulmonology
14.2.4. Gastroenterology
14.2.5. Otolaryngology
14.2.6. Dermatology
14.2.7. Geriatric
14.2.8. Neurology
14.2.9. Orthopedics
14.2.10. Mental
Health
14.2.11. Women's
Health
14.2.12. Others
14.3. Middle
East and Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
End-User
14.3.1. Physicians/Clinicians
14.3.2. Providers
14.3.2.1. Hospitals
14.3.2.2. Urgent
and Acute Care Centers
14.3.2.3. Clinics
14.3.2.4. Primary
Care Centers
14.3.2.5. Senior
Care Facilities
14.3.2.6. Home
–Based care
14.3.2.7. Others
14.3.3. Payers
14.3.3.1. Insurance
Companies
14.3.3.2. Others
14.3.4. Diagnostic
Centers
14.3.5. Research
Laboratories and Organizations
14.3.6. Others
14.4. Middle
East and Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
Type
14.4.1. Device/Wearable-based
14.4.2. Mobile
App-based
14.5. Middle
East and Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
Country
14.5.1. Saudi
Arabia
14.5.1.1. Saudi
Arabia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
14.5.1.1.1. Ophthalmology
14.5.1.1.2. Cardiology
14.5.1.1.3. Pulmonology
14.5.1.1.4. Gastroenterology
14.5.1.1.5. Otolaryngology
14.5.1.1.6. Dermatology
14.5.1.1.7. Geriatric
14.5.1.1.8. Neurology
14.5.1.1.9. Orthopedics
14.5.1.1.10. Mental
Health
14.5.1.1.11. Women's
Health
14.5.1.1.12. Others
14.5.1.2. Saudi
Arabia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
14.5.1.2.1. Physicians/Clinicians
14.5.1.2.2. Providers
14.5.1.2.2.1. Hospitals
14.5.1.2.2.2. Urgent
and Acute Care Centers
14.5.1.2.2.3. Clinics
14.5.1.2.2.4. Primary
Care Centers
14.5.1.2.2.5. Senior
Care Facilities
14.5.1.2.2.6. Home
–Based care
14.5.1.2.2.7. Others
14.5.1.2.3. Payers
14.5.1.2.3.1. Insurance
Companies
14.5.1.2.3.2. Others
14.5.1.2.4. Diagnostic
Centers
14.5.1.2.5. Research
Laboratories and Organizations
14.5.1.2.6. Others
14.5.1.3. Saudi
Arabia Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
14.5.1.3.1. Device/Wearable-based
14.5.1.3.2. Mobile
App-based
14.5.2. UAE
14.5.2.1. UAE
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
14.5.2.1.1. Ophthalmology
14.5.2.1.2. Cardiology
14.5.2.1.3. Pulmonology
14.5.2.1.4. Gastroenterology
14.5.2.1.5. Otolaryngology
14.5.2.1.6. Dermatology
14.5.2.1.7. Geriatric
14.5.2.1.8. Neurology
14.5.2.1.9. Orthopedics
14.5.2.1.10. Mental
Health
14.5.2.1.11. Women's
Health
14.5.2.1.12. Others
14.5.2.2. UAE
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
14.5.2.2.1. Physicians/Clinicians
14.5.2.2.2. Providers
14.5.2.2.2.1. Hospitals
14.5.2.2.2.2. Urgent
and Acute Care Centers
14.5.2.2.2.3. Clinics
14.5.2.2.2.4. Primary
Care Centers
14.5.2.2.2.5. Senior
Care Facilities
14.5.2.2.2.6. Home
–Based care
14.5.2.2.2.7. Others
14.5.2.2.3. Payers
14.5.2.2.3.1. Insurance
Companies
14.5.2.2.3.2. Others
14.5.2.2.4. Diagnostic
Centers
14.5.2.2.5. Research
Laboratories and Organizations
14.5.2.2.6. Others
14.5.2.3. UAE
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
14.5.2.3.1. Device/Wearable-based
14.5.2.3.2. Mobile
App-based
14.5.3. Egypt
14.5.3.1. Egypt
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
14.5.3.1.1. Ophthalmology
14.5.3.1.2. Cardiology
14.5.3.1.3. Pulmonology
14.5.3.1.4. Gastroenterology
14.5.3.1.5. Otolaryngology
14.5.3.1.6. Dermatology
14.5.3.1.7. Geriatric
14.5.3.1.8. Neurology
14.5.3.1.9. Orthopedics
14.5.3.1.10. Mental
Health
14.5.3.1.11. Women's
Health
14.5.3.1.12. Others
14.5.3.2. Egypt
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
14.5.3.2.1. Physicians/Clinicians
14.5.3.2.2. Providers
14.5.3.2.2.1. Hospitals
14.5.3.2.2.2. Urgent
and Acute Care Centers
14.5.3.2.2.3. Clinics
14.5.3.2.2.4. Primary
Care Centers
14.5.3.2.2.5. Senior
Care Facilities
14.5.3.2.2.6. Home
–Based care
14.5.3.2.2.7. Others
14.5.3.2.3. Payers
14.5.3.2.3.1. Insurance
Companies
14.5.3.2.3.2. Others
14.5.3.2.4. Diagnostic
Centers
14.5.3.2.5. Research
Laboratories and Organizations
14.5.3.2.6. Others
14.5.3.3. Egypt
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
14.5.3.3.1. Device/Wearable-based
14.5.3.3.2. Mobile
App-based
14.5.4. Kuwait
14.5.4.1. Kuwait
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
14.5.4.1.1. Ophthalmology
14.5.4.1.2. Cardiology
14.5.4.1.3. Pulmonology
14.5.4.1.4. Gastroenterology
14.5.4.1.5. Otolaryngology
14.5.4.1.6. Dermatology
14.5.4.1.7. Geriatric
14.5.4.1.8. Neurology
14.5.4.1.9. Orthopedics
14.5.4.1.10. Mental
Health
14.5.4.1.11. Women's
Health
14.5.4.1.12. Others
14.5.4.2. Kuwait
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
14.5.4.2.1. Physicians/Clinicians
14.5.4.2.2. Providers
14.5.4.2.2.1. Hospitals
14.5.4.2.2.2. Urgent
and Acute Care Centers
14.5.4.2.2.3. Clinics
14.5.4.2.2.4. Primary
Care Centers
14.5.4.2.2.5. Senior
Care Facilities
14.5.4.2.2.6. Home
–Based care
14.5.4.2.2.7. Others
14.5.4.2.3. Payers
14.5.4.2.3.1. Insurance
Companies
14.5.4.2.3.2. Others
14.5.4.2.4. Diagnostic
Centers
14.5.4.2.5. Research
Laboratories and Organizations
14.5.4.2.6. Others
14.5.4.3. Kuwait
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
14.5.4.3.1. Device/Wearable-based
14.5.4.3.2. Mobile
App-based
14.5.5. South
Africa
14.5.5.1. South
Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
14.5.5.1.1. Ophthalmology
14.5.5.1.2. Cardiology
14.5.5.1.3. Pulmonology
14.5.5.1.4. Gastroenterology
14.5.5.1.5. Otolaryngology
14.5.5.1.6. Dermatology
14.5.5.1.7. Geriatric
14.5.5.1.8. Neurology
14.5.5.1.9. Orthopedics
14.5.5.1.10. Mental
Health
14.5.5.1.11. Women's
Health
14.5.5.1.12. Others
14.5.5.2. South
Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
14.5.5.2.1. Physicians/Clinicians
14.5.5.2.2. Providers
14.5.5.2.2.1. Hospitals
14.5.5.2.2.2. Urgent
and Acute Care Centers
14.5.5.2.2.3. Clinics
14.5.5.2.2.4. Primary
Care Centers
14.5.5.2.2.5. Senior
Care Facilities
14.5.5.2.2.6. Home
–Based care
14.5.5.2.2.7. Others
14.5.5.2.3. Payers
14.5.5.2.3.1. Insurance
Companies
14.5.5.2.3.2. Others
14.5.5.2.4. Diagnostic
Centers
14.5.5.2.5. Research
Laboratories and Organizations
14.5.5.2.6. Others
14.5.5.3. South
Africa Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
14.5.5.3.1. Device/Wearable-based
14.5.5.3.2. Mobile
App-based
14.5.6. Rest of
Middle East & Africa
14.5.6.1. Rest
of Middle East & Africa Virtual Diagnostic Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.6.1.1. Ophthalmology
14.5.6.1.2. Cardiology
14.5.6.1.3. Pulmonology
14.5.6.1.4. Gastroenterology
14.5.6.1.5. Otolaryngology
14.5.6.1.6. Dermatology
14.5.6.1.7. Geriatric
14.5.6.1.8. Neurology
14.5.6.1.9. Orthopedics
14.5.6.1.10. Mental
Health
14.5.6.1.11. Women's
Health
14.5.6.1.12. Others
14.5.6.2. Rest
of Middle East & Africa Virtual Diagnostic Market Revenue (US$ Mn) and
Forecasts, By End-User
14.5.6.2.1. Physicians/Clinicians
14.5.6.2.2. Providers
14.5.6.2.2.1. Hospitals
14.5.6.2.2.2. Urgent
and Acute Care Centers
14.5.6.2.2.3. Clinics
14.5.6.2.2.4. Primary
Care Centers
14.5.6.2.2.5. Senior
Care Facilities
14.5.6.2.2.6. Home
–Based care
14.5.6.2.2.7. Others
14.5.6.2.3. Payers
14.5.6.2.3.1. Insurance
Companies
14.5.6.2.3.2. Others
14.5.6.2.4. Diagnostic
Centers
14.5.6.2.5. Research
Laboratories and Organizations
14.5.6.2.6. Others
14.5.6.3. Rest
of Middle East & Africa Virtual Diagnostic Market Revenue (US$ Mn) and
Forecasts, By Type
14.5.6.3.1. Device/Wearable-based
14.5.6.3.2. Mobile
App-based
14.6. Key
Segment for Channeling Investments
14.6.1. By
Country
14.6.2. By
Application
14.6.3. By
End-User
14.6.4. By Type
15. Latin
America Virtual Diagnostic Market Analysis and Forecasts, 2020 - 2028
15.1. Overview
15.1.1. Latin
America Virtual Diagnostic Market Revenue (US$ Mn)
15.2. Latin
America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
Application
15.2.1. Ophthalmology
15.2.2. Cardiology
15.2.3. Pulmonology
15.2.4. Gastroenterology
15.2.5. Otolaryngology
15.2.6. Dermatology
15.2.7. Geriatric
15.2.8. Neurology
15.2.9. Orthopedics
15.2.10. Mental
Health
15.2.11. Women's
Health
15.2.12. Others
15.3. Latin
America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
15.3.1. Physicians/Clinicians
15.3.2. Providers
15.3.2.1. Hospitals
15.3.2.2. Urgent
and Acute Care Centers
15.3.2.3. Clinics
15.3.2.4. Primary
Care Centers
15.3.2.5. Senior
Care Facilities
15.3.2.6. Home
–Based care
15.3.2.7. Others
15.3.3. Payers
15.3.3.1. Insurance
Companies
15.3.3.2. Others
15.3.4. Diagnostic
Centers
15.3.5. Research
Laboratories and Organizations
15.3.6. Others
15.4. Latin
America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
15.4.1. Device/Wearable-based
15.4.2. Mobile
App-based
15.5. Latin
America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
15.5.1.1.1. Ophthalmology
15.5.1.1.2. Cardiology
15.5.1.1.3. Pulmonology
15.5.1.1.4. Gastroenterology
15.5.1.1.5. Otolaryngology
15.5.1.1.6. Dermatology
15.5.1.1.7. Geriatric
15.5.1.1.8. Neurology
15.5.1.1.9. Orthopedics
15.5.1.1.10. Mental
Health
15.5.1.1.11. Women's
Health
15.5.1.1.12. Others
15.5.1.2. Brazil
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
15.5.1.2.1. Physicians/Clinicians
15.5.1.2.2. Providers
15.5.1.2.2.1. Hospitals
15.5.1.2.2.2. Urgent
and Acute Care Centers
15.5.1.2.2.3. Clinics
15.5.1.2.2.4. Primary
Care Centers
15.5.1.2.2.5. Senior
Care Facilities
15.5.1.2.2.6. Home
–Based care
15.5.1.2.2.7. Others
15.5.1.2.3. Payers
15.5.1.2.3.1. Insurance
Companies
15.5.1.2.3.2. Others
15.5.1.2.4. Diagnostic
Centers
15.5.1.2.5. Research
Laboratories and Organizations
15.5.1.2.6. Others
15.5.1.3. Brazil
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
15.5.1.3.1. Device/Wearable-based
15.5.1.3.2. Mobile
App-based
15.5.2. Argentina
15.5.2.1. Argentina
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Application
15.5.2.1.1. Ophthalmology
15.5.2.1.2. Cardiology
15.5.2.1.3. Pulmonology
15.5.2.1.4. Gastroenterology
15.5.2.1.5. Otolaryngology
15.5.2.1.6. Dermatology
15.5.2.1.7. Geriatric
15.5.2.1.8. Neurology
15.5.2.1.9. Orthopedics
15.5.2.1.10. Mental
Health
15.5.2.1.11. Women's
Health
15.5.2.1.12. Others
15.5.2.2. Argentina
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By End-User
15.5.2.2.1. Physicians/Clinicians
15.5.2.2.2. Providers
15.5.2.2.2.1. Hospitals
15.5.2.2.2.2. Urgent
and Acute Care Centers
15.5.2.2.2.3. Clinics
15.5.2.2.2.4. Primary
Care Centers
15.5.2.2.2.5. Senior
Care Facilities
15.5.2.2.2.6. Home
–Based care
15.5.2.2.2.7. Others
15.5.2.2.3. Payers
15.5.2.2.3.1. Insurance
Companies
15.5.2.2.3.2. Others
15.5.2.2.4. Diagnostic
Centers
15.5.2.2.5. Research
Laboratories and Organizations
15.5.2.2.6. Others
15.5.2.3. Argentina
Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By Type
15.5.2.3.1. Device/Wearable-based
15.5.2.3.2. Mobile
App-based
15.5.3. Rest of
Latin America
15.5.3.1. Rest
of Latin America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
Application
15.5.3.1.1. Ophthalmology
15.5.3.1.2. Cardiology
15.5.3.1.3. Pulmonology
15.5.3.1.4. Gastroenterology
15.5.3.1.5. Otolaryngology
15.5.3.1.6. Dermatology
15.5.3.1.7. Geriatric
15.5.3.1.8. Neurology
15.5.3.1.9. Orthopedics
15.5.3.1.10. Mental
Health
15.5.3.1.11. Women's
Health
15.5.3.1.12. Others
15.5.3.2. Rest
of Latin America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
End-User
15.5.3.2.1. Physicians/Clinicians
15.5.3.2.2. Providers
15.5.3.2.2.1. Hospitals
15.5.3.2.2.2. Urgent
and Acute Care Centers
15.5.3.2.2.3. Clinics
15.5.3.2.2.4. Primary
Care Centers
15.5.3.2.2.5. Senior
Care Facilities
15.5.3.2.2.6. Home
–Based care
15.5.3.2.2.7. Others
15.5.3.2.3. Payers
15.5.3.2.3.1. Insurance
Companies
15.5.3.2.3.2. Others
15.5.3.2.4. Diagnostic
Centers
15.5.3.2.5. Research
Laboratories and Organizations
15.5.3.2.6. Others
15.5.3.3. Rest
of Latin America Virtual Diagnostic Market Revenue (US$ Mn) and Forecasts, By
Type
15.5.3.3.1. Device/Wearable-based
15.5.3.3.2. Mobile
App-based
15.6. Key
Segment for Channeling Investments
15.6.1. By
Country
15.6.2. By
Application
15.6.3. By
End-User
15.6.4. By Type
16. Competitive
Benchmarking
16.1. Market
Share Analysis, 2019
16.2. Global
Presence and Growth Strategies
16.2.1. Mergers
and Acquisitions
16.2.2. Product
Launches
16.2.3. Investments
Trends
16.2.4. R&D
Initiatives
17. Player
Profiles
17.1. AliveCor,
Inc.
17.1.1. Company
Details
17.1.2. Company
Overview
17.1.3. Product
Offerings
17.1.4. Key
Developments
17.1.5. Financial
Analysis
17.1.6. SWOT
Analysis
17.1.7. Business
Strategies
17.2. CapsoVision,
Inc.
17.2.1. Company
Details
17.2.2. Company
Overview
17.2.3. Product
Offerings
17.2.4. Key Developments
17.2.5. Financial
Analysis
17.2.6. SWOT
Analysis
17.2.7. Business
Strategies
17.3. Digital
Diagnostics Inc.
17.3.1. Company
Details
17.3.2. Company
Overview
17.3.3. Product
Offerings
17.3.4. Key
Developments
17.3.5. Financial
Analysis
17.3.6. SWOT
Analysis
17.3.7. Business
Strategies
17.4. dSPACE
GmbH
17.4.1. Company
Details
17.4.2. Company
Overview
17.4.3. Product
Offerings
17.4.4. Key
Developments
17.4.5. Financial
Analysis
17.4.6. SWOT
Analysis
17.4.7. Business
Strategies
17.5. Eyenuk,
Inc.
17.5.1. Company
Details
17.5.2. Company
Overview
17.5.3. Product
Offerings
17.5.4. Key
Developments
17.5.5. Financial
Analysis
17.5.6. SWOT
Analysis
17.5.7. Business
Strategies
17.6. hearX IP
(Pty) Ltd
17.6.1. Company
Details
17.6.2. Company
Overview
17.6.3. Product
Offerings
17.6.4. Key
Developments
17.6.5. Financial
Analysis
17.6.6. SWOT
Analysis
17.6.7. Business
Strategies
17.7. Hill-Rom
Services, Inc.
17.7.1. Company
Details
17.7.2. Company
Overview
17.7.3. Product
Offerings
17.7.4. Key
Developments
17.7.5. Financial
Analysis
17.7.6. SWOT
Analysis
17.7.7. Business
Strategies
17.8. Infermedica
17.8.1. Company
Details
17.8.2. Company
Overview
17.8.3. Product
Offerings
17.8.4. Key
Developments
17.8.5. Financial
Analysis
17.8.6. SWOT
Analysis
17.8.7. Business
Strategies
17.9. Medtronic
17.9.1. Company
Details
17.9.2. Company
Overview
17.9.3. Product
Offerings
17.9.4. Key
Developments
17.9.5. Financial
Analysis
17.9.6. SWOT
Analysis
17.9.7. Business
Strategies
17.10. ResApp
Health Limited
17.10.1. Company
Details
17.10.2. Company
Overview
17.10.3. Product
Offerings
17.10.4. Key
Developments
17.10.5. Financial
Analysis
17.10.6. SWOT
Analysis
17.10.7. Business
Strategies
17.11. Sight
Diagnostics Ltd
17.11.1. Company
Details
17.11.2. Company
Overview
17.11.3. Product
Offerings
17.11.4. Key
Developments
17.11.5. Financial
Analysis
17.11.6. SWOT
Analysis
17.11.7. Business
Strategies
17.12. SkinVision
17.12.1. Company
Details
17.12.2. Company
Overview
17.12.3. Product
Offerings
17.12.4. Key
Developments
17.12.5. Financial
Analysis
17.12.6. SWOT
Analysis
17.12.7. Business
Strategies
17.13. Teckel
Medical
17.13.1. Company
Details
17.13.2. Company
Overview
17.13.3. Product
Offerings
17.13.4. Key
Developments
17.13.5. Financial
Analysis
17.13.6. SWOT
Analysis
17.13.7. Business Strategies
17.14. Other
Industry Participants
18. Key
Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
